Defiance Daily Target 2X Long NVO ETF (NVOX)

NYSEARCA: NVOX · Real-Time Price · USD
14.70
-2.98 (-16.86%)
At close: Feb 5, 2026, 4:00 PM EST
16.73
+2.03 (13.81%)
Pre-market: Feb 6, 2026, 8:12 AM EST
-16.86%
Assets$58.04M
Expense Ratio1.30%
PE Ration/a
Shares Out2.82M
Dividend (ttm)n/a
Dividend Yieldn/a
Ex-Dividend Daten/a
Payout Frequencyn/a
Payout Ration/a
Volume2,370,743
Open15.90
Previous Close17.68
Day's Range14.59 - 16.37
52-Week Low14.59
52-Week High105.60
Betan/a
Holdings12
Inception DateDec 2, 2024

About NVOX

Fund Home Page

The Defiance Daily Target 2X Long NVO ETF (NVOX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to deliver 2x leveraged exposure to the daily share price movement of NOVO Nordisk A/S - ADR (NVO), less fees and expenses, through derivatives like swap agreements. NVOX was launched on Dec 2, 2024 and is issued by Defiance.

Asset Class Equity
Category Trading--Leveraged Equity
Stock Exchange NYSEARCA
Ticker Symbol NVOX
ETF Provider Defiance

Top 10 Holdings

251.88% of assets
NameSymbolWeight
NOVO-NORDISK SWAP MSn/a72.34%
US DOLLARSn/a28.72%
NOVO-NORDISK SWAP CLEARSTREETn/a28.38%
NOVO-NORDISK SWAP BMO-Ln/a25.36%
NOVO-NORDISK A/S-SPONS ADR NOMURAn/a24.61%
NOVO-NORDISK INC SWAP CANTORn/a23.80%
NOVO-NORDISK SWAP MAREXn/a21.84%
OTHER ASSETS AND LIABILITIESn/a12.11%
United States Treasury Bills 0%B.0 02.19.267.57%
First American Government Obligations FundFGXXX7.16%
View More Holdings

Performance

NVOX had a total return of -82.49% in the past year, including dividends. Since the fund's inception, the average annual return has been -87.34%.

News

Defiance Launches NVOX, the First 2X Leveraged Single-Stock ETF on Novo Nordisk

MIAMI, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Defiance ETFs today launched NVOX, the world's first single-stock leveraged ETF for the pharmaceutical stock Novo Nordisk (NYSE: NVO). As the weight loss marke...

Other symbols: NVO
1 year ago - GlobeNewsWire